Literature DB >> 2912502

Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine.

J C Sibille1, H Kondo, P Aisen.   

Abstract

Rat liver ferritin is an effective donor of iron to rat hepatocytes. Uptake of iron from ferritin by the cells is partially inhibited by including apotransferrin in the culture medium, but not by inclusion of diferric transferrin. This inhibition is dependent on the concentration of apotransferrin, with a 30% depression in iron incorporation in the cells detected at apotransferrin concentrations above 40 micrograms/ml. However, apotransferrin does not interfere with uptake of 125I-labeled ferritin, suggesting that apotransferrin decreases retention of iron taken up from ferritin by hepatocytes by sequestering a portion of released iron before it has entered the metabolic pathway of the cells. The iron chelators desferrioxamine (100 microM), citrate (10 mM) and diethylenetriaminepentaacetate (100 microM) reduce iron uptake by the cells by 35, 25 and 8%, respectively. In contrast, 1 mM ascorbate increases iron accumulation by 20%. At a subtoxic concentration of 100 microM, chloroquine depresses ferritin and iron uptake by hepatocytes by more than 50% after 3 h incubation. Chloroquine presumably acts by retarding lysosomal degradation of ferritin and recycling of ferritin receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912502     DOI: 10.1016/0167-4889(89)90162-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  The role of transferrin in the mechanism of cellular iron uptake.

Authors:  K Thorstensen; I Romslo
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

2.  Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.

Authors:  S M Levitz; T S Harrison; A Tabuni; X Liu
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Lysosomotropic agents ameliorate macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: a role for lipid peroxidation.

Authors:  M J Raley; M G Schwacha; D J Loegering
Journal:  Inflammation       Date:  1997-12       Impact factor: 4.092

5.  Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

Authors:  S L Newman; L Gootee; G Brunner; G S Deepe
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine.

Authors:  S L Newman; L Gootee; V Stroobant; H van der Goot; J R Boelaert
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

Review 7.  Oxidative stress and the homeodynamics of iron metabolism.

Authors:  Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-05-11

8.  Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages.

Authors:  S M Levitz; S H Nong; K F Seetoo; T S Harrison; R A Speizer; E R Simons
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.